1. Carlomagno N, Incollingo P, Tammaro V, et al. Diagnostic, predictive, prognostic, and therapeutic molecular biomarkers in third millennium: a breakthrough in gastric cancer. Biomed Res Int. 2017;2017:7869802.
2. Cao J, Qi F, Liu T. Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis. Scand J Gastroen- terol. 2014;49(6):690–704.
3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 coun- tries. CA Cancer J Clin. 2018;68(6):394–424.
4. Varanasi L, Do PM, Goluszko E, Martinez LA. Rad18 is a transcriptional target of E2F3. Cell Cycle. 2012;11(6):1131–41.
5. Hibbert RG, Huang A, Boelens R, Sixma TK. E3 ligase Rad18 promotes monoubiquitination rather than ubiquitin chain forma- tion by E2 enzyme Rad6. Proc Natl Acad Sci USA. 2011;108(14):5590–5.
6. Zou S, Yang J, Guo J, et al. RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway. Cancer Lett. 2018;417:65–74.
7. Suzuki M, Yokobori T, Gombodorj N, et al. High stromal transforming growth factor beta-induced expression is a novel marker of progression and poor prognosis in gastric cancer. J Surg Oncol. 2018;118(6):966–74.
8. Zhang W, Qin Z, Zhang X, Xiao W. Roles of sequential ubiq- uitination of PCNA in DNA-damage tolerance. FEBS Lett. 2011;585(18):2786–94.
9. Hedglin M, Aitha M, Pedley A, Benkovic SJ. Replication protein A dynamically regulates monoubiquitination of proliferating cell nuclear antigen. J Biol Chem. 2019;294(13):5157–68.
10. Garg P, Burgers PM. Ubiquitinated proliferating cell nuclear antigen activates translesion DNA polymerases eta and REV1. Proc Natl Acad Sci USA. 2005;102(51):18361–6.
11. Nakamura T, Ishikawa S, Koga Y, et al. Mutation analysis of Rad18 in human cancer cell lines and non small cell lung cancer tissues. J Exp Clin Cancer Res. 2009;28:106.
12. Durando M, Tateishi S, Vaziri C. A non-catalytic role of DNA polymerase eta in recruiting Rad18 and promoting PCNA monoubiquitination at stalled replication forks. Nucleic Acids Res. 2013;41(5):3079–93.
13. Shiomi N, Mori M, Tsuji H, et al. Human RAD18 is involved in S phase-specific single-strand break repair without PCNA monoubiquitination. Nucleic Acids Res. 2007;35(2):e9.
14. Watanabe K, Tateishi S, Kawasuji M, Tsurimoto T, Inoue H, Yamaizumi M. Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J. 2004;23(19):3886–96.
15. Liu T, Chen H, Kim H, Huen MS, Chen J, Huang J. RAD18- BRCTx interaction is required for efficient repair of UV-induced DNA damage. DNA Repair (Amst). 2012;11(2):131–8.
16. Yan X, Chen J, Meng Y, et al. RAD18 may function as a pre- dictor of response to preoperative concurrent chemoradiotherapy in patients with locally advanced rectal cancer through caspase-9- caspase-3-dependent apoptotic pathway. Cancer Med. 2019;8(6):3094–104.
17. Lou P, Zou S, Shang Z, et al. RAD18 contributes to the migration and invasion of human cervical cancer cells via the interleuk- in1beta pathway. Mol Med Rep. 2019;20(4):3415–23.
18. Wong RP, Aguissa-Toure AH, Wani AA, et al. Elevated expression of Rad18 regulates melanoma cell proliferation. Pig- ment Cell Melanoma Res. 2012;25(2):213–8.